Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine - Takeaways - MDSpire

Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine

  • By

  • Lisa R Metsch

  • Daniel J Feaster

  • Lauren K Gooden

  • Yue Pan

  • Carrigan L Parish

  • Drenna Waldrop

  • Allan Rodriguez

  • Jonathan A Colasanti

  • Pedro C Castellón

  • Wendy S Armstrong

  • Michael Miller

  • Christin Root

  • Margaret R Pereyra

  • Carlos del Rio

  • March 3, 2025

  • 0 min

Share

  • 1

    Project RETAIN aimed to improve viral suppression in HIV-positive individuals who use cocaine through an integrated care intervention.

  • 2

    The study involved 360 participants, randomized to treatment as usual or an intervention including patient navigation and behavioral therapies.

  • 3

    No significant difference in viral suppression was observed between the intervention group (15.6%) and treatment as usual (17.1%).

  • 4

    The intervention group showed higher participation in substance use treatment (87.0%) compared to treatment as usual (7.2%).

  • 5

    Despite increased treatment participation, both groups experienced similar declines in substance use, highlighting the need for more effective interventions.

Original Source(s)

Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine

  • by Lisa R Metsch, Daniel J Feaster, Lauren K Gooden, Yue Pan, Carrigan L Parish, Drenna Waldrop, Allan Rodriguez, Jonathan A Colasanti, Pedro C Castellón, Wendy S Armstrong, Michael Miller, Christin Root, Margaret R Pereyra, Carlos del Rio

  • March 3, 2025

Related Content

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Hospital-Treated Infections Linked to Dementia Risk

Investigators identify 29 conditions associated with dementia risk in nationwide registry analysis.